UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 280

Sortiert nach

Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives

Journal of clinical oncology, 2018-01, Vol.36 (2), p.160-167

2018

Link zum Volltext

Verfügbarkeit prüfen

Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas

The New England journal of medicine, 2016-12, Vol.375 (26), p.2550-2560

2016

Link zum Volltext

Verfügbarkeit prüfen

Understanding and Managing Methotrexate Nephrotoxicity

The oncologist (Dayton, Ohio), 2006-06, Vol.11 (6), p.694-703

2006

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal association between executive function and academic achievement in children with neurofibromatosis type 1 and plexiform neurofibromas

Journal of the International Neuropsychological Society, 2023-11, Vol.29 (9), p.839-849

2023

Link zum Volltext

Verfügbarkeit prüfen

Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors

Current oncology reports, 2009-07, Vol.11 (4), p.322-328

Widemann, Brigitte C.

2009

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions

Neuro-oncology (Charlottesville, Va.), 2020-09, Vol.22 (9), p.1368-1378

2020

Link zum Volltext

Verfügbarkeit prüfen

The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors

Neuro-oncology (Charlottesville, Va.), 2018-05, Vol.20 (6), p.818-825

2018

Link zum Volltext

Verfügbarkeit prüfen

Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1

Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (12), p.1643-1651

2018

Link zum Volltext

Verfügbarkeit prüfen

Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future

JNCI : Journal of the National Cancer Institute, 2017-08, Vol.109 (8)

2017

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas

Journal of clinical oncology, 2016-05, Vol.34 (14), p.1669-1675

2016

Link zum Volltext

Verfügbarkeit prüfen

Development and psychometric testing of a pediatric chronic graft-versus-host disease symptom scale: protocol for a two-phase, mixed methods study

Frontiers in psychology, 2024-01, Vol.14, p.1243005-1243005

2024

Link zum Volltext

Verfügbarkeit prüfen

Safe marginal resection of atypical neurofibromas in neurofibromatosis type 1

Journal of neurosurgery, 2020-11, Vol.133 (5), p.1516-1526

2020

Link zum Volltext

Verfügbarkeit prüfen

Management of neurofibromatosis type 1-associated plexiform neurofibromas

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (11), p.1827-1844

2022

Link zum Volltext

Verfügbarkeit prüfen

Recommendations for imaging tumor response in neurofibromatosis clinical trials

Neurology, 2013-11, Vol.81 (21 Suppl 1), p.S33

2013

Link zum Volltext

Verfügbarkeit prüfen

Glucarpidase, Leucovorin, and Thymidine for High-Dose Methotrexate-Induced Renal Dysfunction: Clinical and Pharmacologic Factors Affecting Outcome

Journal of clinical oncology, 2010-09, Vol.28 (25), p.3979-3986

2010

Link zum Volltext

Verfügbarkeit prüfen

Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies

Sarcoma, 2017, Vol.2017, p.7429697-10

2017

Link zum Volltext

Verfügbarkeit prüfen

Sirolimus for non-progressive NF1-associated plexiform neurofibromas: An NF clinical trials consortium phase II study

Pediatric blood & cancer, 2014-06, Vol.61 (6), p.982-986

2014

Link zum Volltext

Verfügbarkeit prüfen

Advances, challenges and progress in pediatric hematology and oncology

Current opinion in pediatrics, 2023-02, Vol.35 (1), p.39

Widemann, Brigitte C

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial and Pharmacokinetic Study of Lexatumumab in Pediatric Patients With Solid Tumors

Journal of clinical oncology, 2012-11, Vol.30 (33), p.4141-4147

2012

Link zum Volltext

Verfügbarkeit prüfen

Pediatric adrenocortical carcinoma

Frontiers in endocrinology (Lausanne), 2022-10, Vol.13, p.961650-961650

2022

Link zum Volltext

Verfügbarkeit prüfen

Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1

Orphanet journal of rare diseases, 2012-10, Vol.7 (1), p.75-75

2012

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint inhibitors for refractory childhood cancers

The lancet oncology, 2020-01, Vol.21 (1), p.14-15

Widemann, Brigitte C

2020

Link zum Volltext

Verfügbarkeit prüfen

Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023)

Sarcoma, 2020, Vol.2020, p.5784876-8

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 280

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(276)
Mit Volltextzugriff
(262)

Publikationsform

Artikel
(278)
Buchkapitel
(2)

Sprache

Englisch
(280)
Japanisch
(25)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives

Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma

Understanding and Managing Methotrexate Nephrotoxicity

Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study

Longitudinal association between executive function and academic achievement in children with neurofibromatosis type 1 and plexiform neurofibromas

Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors

Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions

The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors

Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1

Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the Future

Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas

Development and psychometric testing of a pediatric chronic graft-versus-host disease symptom scale: protocol for a two-phase, mixed methods study

Safe marginal resection of atypical neurofibromas in neurofibromatosis type 1

Management of neurofibromatosis type 1-associated plexiform neurofibromas

Recommendations for imaging tumor response in neurofibromatosis clinical trials

Glucarpidase, Leucovorin, and Thymidine for High-Dose Methotrexate-Induced Renal Dysfunction: Clinical and Pharmacologic Factors Affecting Outcome

Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies

Sirolimus for non-progressive NF1-associated plexiform neurofibromas: An NF clinical trials consortium phase II study

Advances, challenges and progress in pediatric hematology and oncology

Phase I Trial and Pharmacokinetic Study of Lexatumumab in Pediatric Patients With Solid Tumors

Pediatric adrenocortical carcinoma

Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1

Immune checkpoint inhibitors for refractory childhood cancers

Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023)

Suchergebnisse filtern